N
ISSUER//CIK 0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 46.4 KBNEOPROBE CORPJun 1, 3:37 PM ET·0000949265-06-000382
- 416.4 KBNEOPROBE CORPMay 31, 5:30 PM ET·0000949265-06-000381
- 8-K131.2 KBNEOPROBE CORPMay 2, 5:20 PM ET·0001144204-06-018087
- 8-K8.6 KBNEOPROBE CORPJan 11, 3:58 PM ET·0001144204-06-001182
- 8-K27.4 KBNEOPROBE CORPMay 2, 7:26 PM ET·0001144204-05-013717
- 8-K43.5 KBNEOPROBE CORPJan 5, 3:10 PM ET·0001144204-05-000351
- 45.7 KBNEOPROBE CORPAug 20, 2:20 PM ET·0000949265-04-000675
- 8-K22.4 KBNEOPROBE CORPAug 10, 3:28 PM ET·0000950152-04-006079
- 45.7 KBNEOPROBE CORPMay 26, 4:19 PM ET·0000949265-04-000474
- 46.5 KBNEOPROBE CORPMay 25, 4:00 PM ET·0000949265-04-000471
Insiders
10Tickers
No tickers on record
Addresses
business
4995 BRADENTON AVENUE SUITE 240
DUBLIN, OH, 43017
mailing
4995 BRADENTON AVENUE SUITE 240
DUBLIN, OH, 43017
Former Names
- NEOPROBE CORP2011-12-30